Skip to main content
logo
AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
184.07
+0.47 (0.26%)
At close: Mar 23, 2026, 4:00 PM EDT
184.06
-0.01 (-0.01%)
After-hours: Mar 23, 2026, 6:03 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Oncology Revenue
25.62B20.28B
Oncology Revenue Growth
26.35%18.26%
BioPharmaceuticals: CVRM Revenue
12.77B12.45B
BioPharmaceuticals: CVRM Revenue Growth
2.62%17.60%
BioPharmaceuticals: R&I Revenue
8.87B7.42B
BioPharmaceuticals: R&I Revenue Growth
19.55%21.43%
BioPharmaceuticals V&I Revenue
1.27B1.06B
BioPharmaceuticals V&I Revenue Growth
19.85%4.54%
Rare Disease Revenue
9.13B8.67B
Rare Disease Revenue Growth
5.28%11.64%
Other Medicines Revenue
988.00M1.07B
Other Medicines Revenue Growth
-7.92%-8.76%
Collaboration Revenue
99.00M3.14B
Collaboration Revenue Growth
-96.84%55.05%
Revenue (Total)
58.74B54.07B
Revenue (Total) Growth
8.63%18.04%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
UK Revenue
4.36B4.74B
UK Revenue Growth
-8.04%40.74%
Rest of Europe Revenue
13.46B11.70B
Rest of Europe Revenue Growth
14.97%20.34%
The Americas Revenue
27.56B24.99B
The Americas Revenue Growth
10.28%20.31%
Asia, Africa & Australasia Revenue
13.37B12.64B
Asia, Africa & Australasia Revenue Growth
5.75%5.81%
Revenue (Total)
58.74B54.07B
Revenue (Total) Growth
8.63%18.04%

EBIT by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
UK Operating Profit
7.07B2.68B
UK Operating Profit Growth
163.66%303.01%
Rest of Europe Operating Profit
5.23B5.92B
Rest of Europe Operating Profit Growth
-11.66%21.27%
The Americas Operating Profit
440.00M423.00M
The Americas Operating Profit Growth
4.02%-71.71%
Asia, Africa & Australasia Operating Profit
1.00B976.00M
Asia, Africa & Australasia Operating Profit Growth
2.87%-14.98%
Operating Income (Total)
13.74B10.00B
Operating Income (Total) Growth
37.39%22.09%

Capital Expenditures by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
UK Assets Acquired
1.76B582.00M
UK Assets Acquired Growth
202.23%-28.32%
Rest of Europe Assets Acquired
2.81B2.23B
Rest of Europe Assets Acquired Growth
26.47%25.71%
The Americas Assets Acquired
1.88B3.93B
The Americas Assets Acquired Growth
-52.18%103.90%
Asia, Africa & Australasia Assets Acquired
557.00M1.39B
Asia, Africa & Australasia Assets Acquired Growth
-60.04%1091.45%
Updated Feb 10, 2026. Data Source: Fiscal.ai.